1
|
Xu H, Chai CP, Miao X, Tang H, Hu JJ, Zhang H, Zhou WC. Establishment and characterization of a new human ampullary carcinoma cell line, DPC-X1. World J Gastroenterol 2023; 29:2642-2656. [PMID: 37213400 PMCID: PMC10198051 DOI: 10.3748/wjg.v29.i17.2642] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 02/17/2023] [Accepted: 04/13/2023] [Indexed: 05/23/2023] Open
Abstract
BACKGROUND An in-depth study of the pathogenesis and biological characteristics of ampullary carcinoma is necessary to identify appropriate treatment strategies. To date, only eight ampullary cancer cell lines have been reported, and a mixed-type ampullary carcinoma cell line has not yet been reported.
AIM To establish a stable mixed-type ampullary carcinoma cell line originating from Chinese.
METHODS Fresh ampullary cancer tissue samples were used for primary culture and subculture. The cell line was evaluated by cell proliferation assays, clonal formation assays, karyotype analysis, short tandem repeat (STR) analysis and transmission electron microscopy. Drug resistances against oxaliplatin, paclitaxel, gemcitabine and 5-FU were evaluated by cell counting kit-8 assay. Subcutaneous injection 1 × 106 cells to three BALB/c nude mice for xenograft studies. The hematoxylin-eosin staining was used to detect the pathological status of the cell line. The expression of biomarkers cytokeratin 7 (CK7), cytokeratin 20 (CK20), cytokeratin low molecular weight (CKL), Ki67 and carcinoembryonic antigen (CEA) were determined by immunocytochemistry assay.
RESULTS DPC-X1 was continuously cultivated for over a year and stably passaged for more than 80 generations; its population doubling time was 48 h. STR analysis demonstrated that the characteristics of DPC-X1 were highly consistent with those of the patient’s primary tumor. Furthermore, karyotype analysis revealed its abnormal sub-tetraploid karyotype. DPC-X1 could efficiently form organoids in suspension culture. Under the transmission electron microscope, microvilli and pseudopods were observed on the cell surface, and desmosomes were visible between the cells. DPC-X1 cells inoculated into BALB/C nude mice quickly formed transplanted tumors, with a tumor formation rate of 100%. Their pathological characteristics were similar to those of the primary tumor. Moreover, DPC-X1 was sensitive to oxaliplatin and paclitaxel and resistant to gemcitabine and 5-FU. Immunohistochemistry showed that the DPC-X1 cells were strongly positive for CK7, CK20, and CKL; the Ki67 was 50%, and CEA was focally expressed.
CONCLUSION Here, we have constructed a mixed-type ampullary carcinoma cell line that can be used as an effective model for studying the pathogenesis of ampullary carcinoma and drug development.
Collapse
Affiliation(s)
- Hao Xu
- The Forth Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
| | - Chang-Peng Chai
- The Forth Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
| | - Xin Miao
- State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Animal Virology of the Ministry of Agriculture, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, Gansu Province, China
| | - Huan Tang
- The Second Clinical Medical College, Lanzhou University, Lanzhou 730000, Gansu Province, China
| | - Jin-Jing Hu
- The Forth Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
| | - Hui Zhang
- Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
| | - Wen-Ce Zhou
- The Second Clinical Medical College, Lanzhou University, Lanzhou 730000, Gansu Province, China
- Department of General Surgery, The Second Hospital of Lanzhou University, Lanzhou 730000, Gansu Province, China
| |
Collapse
|
2
|
Peng J, Xu H, Cai J. Establishment and characterization of a new gastric cancer cell line, XGC-1. Cancer Cell Int 2020; 20:437. [PMID: 32943986 PMCID: PMC7487967 DOI: 10.1186/s12935-020-01536-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2020] [Accepted: 09/01/2020] [Indexed: 12/15/2022] Open
Abstract
Background To establish a primary human gastric cancer cell line. Methods Fresh gastric cancer tissue samples were separated into a cell suspension, and DMEM/F12 medium containing 10% foetal bovine serum was used for primary culture and subculture. The morphology of the cells was observed under a light microscope, and the cell growth curve was plotted. A soft agar colony formation assay was used to detect the colony formation ability of the cell line. Immunohistochemical methods were used to detect cytokeratin, vimentin and Ki-67, the chromosome G banding method was used to analyse the karyotype of the cells, and the tumourigenic ability of the cells was detected by subcutaneous inoculation of BALB/C nude mice. Results We established a gastric cancer cell line from a 68-year-old male patient. This gastric cancer cell line was named XGC-1 and had a doubling time of approximately 48 h. The cell line displayed strong colony formation ability and tumourigenicity in BALB/C nude mice and had complicated chromosomal abnormalities. When nutrients were insufficient, the cells shed and floated in the medium, but adherent growth was observed in nutrient-rich conditions. Conclusions The XGC-1 cell line will be useful for future studies of gastric cancer development, progression, metastasis and therapy.
Collapse
Affiliation(s)
- Jigui Peng
- Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, Xiamen, 361004 Fujian China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004 Fujian China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004 Fujian China
| | - Hao Xu
- Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004 Fujian China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004 Fujian China.,The Second Department of General Surgery, the First Hospital of Lanzhou University, No. 1, Donggang West Road, Lanzhou, 730000 Gansu China
| | - Jianchun Cai
- Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, Xiamen, 361004 Fujian China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004 Fujian China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004 Fujian China
| |
Collapse
|
3
|
Cheng J, Zhuo H, Wang L, Zheng W, Chen X, Hou J, Zhao J, Cai J. Identification of the Combinatorial Effect of miRNA Family Regulatory Network in Different Growth Patterns of GC. MOLECULAR THERAPY-ONCOLYTICS 2020; 17:531-546. [PMID: 32637572 PMCID: PMC7321821 DOI: 10.1016/j.omto.2020.03.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Accepted: 03/24/2020] [Indexed: 12/24/2022]
Abstract
According to the growth pattern, gastric cancer (GC) could be classified into expanding-type GC and infiltrative-type GC (Ming’s classification). The growth pattern of GC is often related to the malignant degree, invasion, metastasis, and other pathological characteristics of tumors. MicroRNAs (miRNAs) play important roles in modulating gene expression during the GC development. In this study, miR-29s were significantly correlated with the gastric carcinogenesis and Ming’s classification. Biological function of miR-29s is most closely related to the pathway of extracellular matrix (ECM)-receptor interaction. ECM structural assembly, cell movement, and cell adhesion are the main functional categories of target genes in this pathway. Among these targets, the COL4A1 gene ranked at the top in the association analysis of combined miR-29s biological function and GC subtype, and miR-29s inhibited its translation by binding to the 3′ UTR region. Infiltrative-type GC cells secrete a higher level of COL4A1 protein than do expanding-type GC cells. The expression of COL4A1 in GC is correlated with clinicopathological features. Downregulation of COL4A1 expression significantly inhibited the migration and invasion of GC cells. High COL4A1 expression was correlated with poor prognosis in survival analysis. The miR-29s regulatory network may affect the development of growth patterns and pathological progress of GC by regulating the function of COL4A1.
Collapse
Affiliation(s)
- Jia Cheng
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China
| | - Huiqin Zhuo
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China
| | - Lin Wang
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China
| | - Wei Zheng
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China
| | - Xin Chen
- Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, China
| | - Jingjing Hou
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China
| | - Jiabao Zhao
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China
| | - Jianchun Cai
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China.,Institute of Gastrointestinal Oncology, School of Medicine, Xiamen University, Xiamen, Fujian 361004, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, Fujian 361004, China.,Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, China
| |
Collapse
|
4
|
Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng J, Hou J, Lin L, Cai J. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Transl Med 2018; 16:216. [PMID: 30068360 PMCID: PMC6071397 DOI: 10.1186/s12967-018-1582-8] [Citation(s) in RCA: 116] [Impact Index Per Article: 19.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2018] [Accepted: 07/17/2018] [Indexed: 02/06/2023] Open
Abstract
Background Little has been known about the role of non-coding RNA regulatory network in the patterns of growth and invasiveness of gastric cancer (GC) development. Methods MicroRNAs (miRNAs) microarray was used to screen differential miRNA expression profiles in Ming’s classification. The significant differential expressions of representative miRNAs and their interacting circular RNA (circRNA) were confirmed in GC cell line and 63 pairs of GC samples. Then, a circRNA/miRNA network was constructed by bioinformatics approaches to identify molecular pathways. Finally, we explored the clinical value of the common targets in the pathway by using receiver operating characteristic curve and survival analysis. Results Significantly differential expressed miRNAs were found in two pathological types of GC. Both of miR-124 and miR-29b were consistently down-regulated in GC. CircHIPK3 could play a negative regulatory role on miR-124/miR-29b expression and associated with T stage and Ming’s classification in GC. The bioinformatics analyses showed that targets expression of circHIPK3-miR-124/miR-29b axes in cancer-related pathways was able to predict the status of GC and associated with individual survival time. Conclusions The targets of circHIPK3-miR-124/miR-29b axes involved in the progression of GC. CircHIPK3 could take part in the proliferation process of GC cell and may be potential biomarker in histological classification of GC. Electronic supplementary material The online version of this article (10.1186/s12967-018-1582-8) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Jia Cheng
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004, Fujian, China
| | - Huiqin Zhuo
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004, Fujian, China
| | - Mao Xu
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004, Fujian, China
| | - Linpei Wang
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China
| | - Hao Xu
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China
| | - Jigui Peng
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China
| | - Jingjing Hou
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004, Fujian, China
| | - Lingyun Lin
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China.,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China.,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004, Fujian, China
| | - Jianchun Cai
- Department of Gastrointestinal Surgery, Zhongshan Hospital, Xiamen University, Xiamen, 361004, Fujian, China. .,Institute of Gastrointestinal Oncology, Medical College of Xiamen University, Xiamen, 361004, Fujian, China. .,Xiamen Municipal Key Laboratory of Gastrointestinal Oncology, Xiamen, 361004, Fujian, China. .,Union Hospital, Fujian Medical University, Fuzhou, 350001, Fujian, China.
| |
Collapse
|